AC
Aristides Capital Portfolio holdings
AUM
$314M
1-Year Return
20.81%
This Quarter Return
+7.4%
1 Year Return
+20.81%
3 Year Return
+65.2%
5 Year Return
+141.08%
10 Year Return
–
AUM
$320M
AUM Growth
+$79.1M
(+33%)
Cap. Flow
+$59M
Cap. Flow
% of AUM
18.45%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
359
New
119
Increased
136
Reduced
19
Closed
59
Top Buys
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$8.79M |
| 2 |
NTG
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
|
$5.01M |
| 3 |
Turning Point Brands
TPB
|
$3.67M |
| 4 |
Capri Holdings
CPRI
|
$2.95M |
| 5 |
TTP
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
|
$2.87M |
Sector Composition
| 1 | Technology | 16.03% |
| 2 | Industrials | 9.46% |
| 3 | Financials | 9.33% |
| 4 | Consumer Discretionary | 8.81% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Alector
ALEC
$305M
| $201K | 0.04% |
+106,600
| New | +$201K |
|
227
Atkore
ATKR
$1.99B
| $200K | 0.04% |
+2,400
| New | +$200K |
|
228
Myriad Genetics
MYGN
$615M
| $199K | 0.04% |
+14,500
| New | +$199K |
|
229
Tango Therapeutics
TNGX
$772M
| $199K | 0.04% |
+64,300
| New | +$199K |
|
|
HPP
230
Hudson Pacific Properties
HPP
$1.16B
| $197K | 0.04% |
+65,100
| New | +$197K |
|
231
Syndax Pharmaceuticals
SNDX
$1.47B
| $197K | 0.04% |
+14,900
| New | +$197K |
|
232
Pyxis Oncology
PYXS
$118M
| $193K | 0.04% |
+124,000
| New | +$193K |
|
233
Lexeo Therapeutics
LXEO
$271M
| $193K | 0.04% |
+29,285
| New | +$193K |
|
234
Leslie's
LESL
$64.6M
| $192K | 0.04% |
+85,900
| New | +$192K |
|
235
PagSeguro Digital
PAGS
$2.8B
| $191K | 0.04% |
+30,500
| New | +$191K |
|
236
Olema Pharmaceuticals
OLMA
$570M
| $189K | 0.04% |
+32,500
| New | +$189K |
|
237
Perspective Therapeutics
CATX
$257M
| $187K | 0.04% |
+58,700
| New | +$187K |
|
238
Regenxbio
RGNX
$490M
| $187K | 0.04% |
+24,200
| New | +$187K |
|
239
Viasat
VSAT
$3.98B
| $186K | 0.04% |
+21,800
| New | +$186K |
|
240
StoneCo
STNE
$4.63B
| $184K | 0.04% |
+23,100
| New | +$184K |
|
|
NKLA
241
DELISTED
Nikola Corporation Common Stock
NKLA
| $182K | 0.04% |
+153,275
| New | +$182K |
|
242
Intellia Therapeutics
NTLA
$1.29B
| $182K | 0.04% |
+15,600
| New | +$182K |
|
|
PCN
243
PIMCO Corporate & Income Strategy Fund
PCN
$839M
| $180K | 0.04% |
+13,420
| New | +$180K |
|
244
Relay Therapeutics
RLAY
$710M
| $179K | 0.04% |
+43,400
| New | +$179K |
|
|
NOVA
245
DELISTED
Sunnova Energy
NOVA
| $177K | 0.04% |
+51,500
| New | +$177K |
|
246
Luminar Technologies
LAZR
$114M
| $176K | 0.04% |
+32,800
| New | +$176K |
|
247
Cabaletta Bio
CABA
$155M
| $171K | 0.04% |
+75,400
| New | +$171K |
|
248
FuelCell Energy
FCEL
$92.3M
| $170K | 0.03% |
+18,800
| New | +$170K |
|
249
AnaptysBio
ANAB
$613M
| $168K | 0.03% |
+12,700
| New | +$168K |
|
250
Editas Medicine
EDIT
$248M
| $168K | 0.03% |
+131,900
| New | +$168K |
|